Evidence map›Paper›PMID 30713685›Full record

ArticleRSC advances2018

Platelet aggregation induced by polystyrene and platinum nanoparticles is dependent on surface area.

Fatima Zia, Michaela Kendall, Steve P Watson, Paula M Mendes

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Inhibition of Platelet Adhesion from Surface Modified Polyurethane Membranes.Biomedical journal of scientific & technical research · 2020
    Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Fatima ZiaSchool of Chemical Engineering, College of Engineering and Physical Sciences, University of Birmingham B15 2TT, UK. Email: p.m.mendes@bham.ac.uk.
Michaela KendallAdelan/School of Engineering, Aston University, Birmingham B4 7ET, UK. http://www.adelan.co.uk.
Steve P WatsonCentre of Membrane Proteins and Receptors (COMPARE), Universities of Birmingham and Nottingham, The Midlands, UK.ORCID 0000-0002-7846-7423
Paula M MendesSchool of Chemical Engineering, College of Engineering and Physical Sciences, University of Birmingham B15 2TT, UK. Email: p.m.mendes@bham.ac.uk.ORCID 0000-0001-6937-7293
University of Birmingham · GBAston University · GB

Funding

British Heart Foundation CH/03/003/15571
6 · The paper itself

Abstract

Nanoparticles are key components underlying recent technological advances in various industrial and medical fields, and thus understanding their mode of interaction with biological systems is essential. However, while several nanoparticle systems have been shown to interact with blood platelets, many questions remain concerning the mechanisms of platelet activation and the role that the physicochemical properties of nanoparticles play in inducing platelet aggregation. Here, using negatively charged polystyrene nanoparticles with sizes of 25, 50, 119, 151, 201 nm and negatively charged platinum nanoparticles with sizes of 7 and 73 nm, we show that it is not the size of the nanoparticles but rather the nanoparticle surface area that is critical in mediating the effects on platelet activation. The nanoparticles stimulate platelet aggregation through passive (agglutination) and activation of integrin αIIbβ3 through a pathway regulated by Src and Syk tyrosine kinase.

Identifiers

PMID30713685
PMCPMC6333253
OpenAlexW2900565379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.